Search the site

Tate & Lyle PLC (Tate & Lyle) announces the exit from the substantial part of its European Bulk Ingredients business and the re-structuring of its SPLENDA ® Sucralose business to further focus on and strengthen Speciality Food Ingredients.

Tate & Lyle PLC Full Year Results Announcement - May 2015 1) Press release Please download the PDF for full press release.

Attendees to enjoy healthier twist on culinary classics as homage to IFT 75th anniversary, featuring a  root beer craft soda sweetened with new DOLCIA PRIMA ® Allulose.

ISSUE OF DEBT - NOT FOR DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA (OR TO U.S. PERSONS), AUSTRALIA, CANADA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES OF SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.

This Trading Statement covers the period from 1 April 2015 to 30 June 2015, which is the first quarter of the financial year.

London, August 18 2015 – Tate & Lyle Ventures announces a $2 million investment in Evolve BioSystems, Inc. a microbiome spin-out company from the University of California at Davis.

Tate & Lyle Launches New Resource to Help Food and Beverage Manufacturers Unlock the Benefits of Fibre. New website features a suite of information for healthier and tastier fibre formulations.

London, 15 September 2015 – Tate & Lyle Ventures announced today that its Fund I portfolio company Lumora Ltd has been sold to ERBA Diagnostics Mannheim GmbH (ERBA), a global in vitro diagnostics company.